American Century Companies’s Arcturus Therapeutics ARCT Stock Holding History

American Century Companies's ARCT Position: Q2 2026 in Review

American Century Companies reduced its Arcturus Therapeutics (ARCT) stake by 0.99% in Q2 2026, selling an estimated $5.13K and leaving 65,361 shares worth $439K. The position accounts for ﹤0.01% of the portfolio, ranked #2613.

American Century Companies first reported a position in ARCT in Q2 2023 and has held it in 13 quarters since. The position peaked at $7.83M in Q1 2024. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

• American Century Companies held 65,361 shares of Arcturus Therapeutics worth $439K as of Q2 2026.
• American Century Companies sold 651 Arcturus Therapeutics shares in Q2 2026, an estimated $5.13K.
• Arcturus Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2613 holding.
• American Century Companies first reported a position in Arcturus Therapeutics in Q2 2023 and has held it in 13 quarters since.
• American Century Companies's Arcturus Therapeutics position peaked at $7.83M in Q1 2024.
• 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.